Veterinary CRO & CDMO Market Size, Share, By Animal Type (Companion Animals and Livestock Animals), By Service (Discovery, Development, Manufacturing, Packaging and Labeling, and Market Approval and Post-Marketing), By Application (Medicines and Medical Devices) and By Region - Trends, Analysis and Forecast till 2034

• By 2034, the veterinary CRO & CDMO market size is expected to be worth USD 15.2 billion.
• The target market was worth USD 6.69 Billion in 2024.
• The market is expected to grow at a CAGR of 9.5% during the forecast period.

Veterinary CROs and CDMOs are highly specialized service providers dedicated to developing animal health. These organizations cover all-inclusive services from preclinical activities to product commercialization for developing and commercializing veterinary pharmaceuticals, biologics, and medical devices. The research and development phase of product development in a company is primarily the most targeted by CROs. This comprises preclinical studies, conduct of clinical trials, regulatory affairs, and data management. Additionally, the growing number of livestock and the heightened emphasis on pet healthcare fuel the need for novel treatments, further driving the market expansion.

Key Takeaways:

• North America is expected to dominate the market owing to the rigid regulatory frameworks, well established players, and advanced infrastructure.
• Asia Pacific is projected to witness the fastest growth in the market owing to the rising disposable income, pet adoption, and high investments in the animal healthcare sector.

                             To Know More, Request Free Sample Report

Increasing Prevalence of Animal Diseases to Boost Market Expansion

• The increased incidence of zoonotic diseases is presenting major concerns for both health and animal welfare. This, in turn, imparts a pressing need to develop the most appropriate ways of prevention, diagnosis, and treatment, which has generally increased demand for veterinary pharmaceuticals. The CROs and CDMOs are also vital for expediting the development, safety, and efficacy of such important medicated drugs and ensuring improved outcomes in animal health.

Rising Pet Population and Humanization of Pets to Augment Market Growth

• As the number of companion animals increases worldwide and with the increasing trend of humanization of pets, demand for advanced veterinary care also rises. Added to this is that pet owners seek quality healthcare options for their beloved companions, thereby stimulating the need to develop innovative veterinary products and services. Such increased demand thus translates to a higher volume of drug development projects for CROs and CDMOs, thus stimulating market growth.

Increasing Investment in Animal Healthcare to Boost Market Expansion

• Growing animal health and welfare awareness is pumping huge investments into veterinary research and development. Pharmaceutical companies, biotechnology firms, and government agencies invest heavily in developing novel and advanced treatments against animal diseases. The CROs and CDMOs benefit from the increased investments through these critical services that help support research efforts, drug development pace, product quality, and compliance.

Restraints:

High Development Costs, Small Market Size, and Regulatory Hurdles May Impede Market Growth

• Veterinary drug development and manufacturing are expensive processes; they could be even better if the market for veterinary drugs was as large as it is for human pharmaceuticals. This impacts the variety of projects CROs and CDMOs can execute and, consequently, their potential revenue. That said, growth in this market is now driven by increased valuing of animal health, and with time and further investment, economies of scale may help temper at least some of these cost challenges a little.

• Ensuring compliance with a complex, changing veterinary drug regulatory landscape is a significant challenge for CROs and CDMOs regarding compliance and time-to-market. Keeping pace with changing regulations and following guidelines requires substantial resources. However, those CROs and CDMOs with robust regulatory expertise can set themselves apart and create a competitive edge.

Opportunities:

Emerging New Entries in the Market to Boost Market Opportunities in the Future

• The growing pet population and increasing awareness of animal health in developing economies spell huge growth potential for veterinary CROs and CDMOs. A strong presence in such markets, coupled with the requirement of tailoring services to local needs and regulations, will enable the realization of a large customer base. It is also the case that rising exposure to zoonotic diseases in emerging markets increases the requirement for efficient animal healthcare, which will raise demand for professional veterinary products and services.

• In this regard, paying specific attention to oncology, infectious diseases, companion animal care, or other focused therapeutic areas can lend a differentiated market-leading position to CROs and CDMOs by better addressing the increasing demand for specialized treatments. CROs achieve this by putting firms in a position to gain in-depth expertise and strong relations with clients interested in certain diseases. Besides, in contributing to developing trends in veterinary medicine, such as personalized medicine and gene therapy, the CROs and CDMOs set themselves at the forefront in their respective activities.

The veterinary CRO & CDMO market is segmented into animal type, service, applications, and region.

Animal Type Insights:

Based on animal type, the market is classified into companion animals and livestock animals. The companion animals segment is expected to hold the largest veterinary CRO & CDMO market share during the forecast period owing to increasing bonding between humans and animals globally.

Service Insights:

By service, the market is divided into discovery, development, manufacturing, packaging and labeling, and market approval and post-marketing. The discovery segment is expected to lead the market as CROs are very important for discovery as it provide intellectual input for target identification.

Application Insights:

By application, the market is bifurcated into medicines and medical devices. The market is being dominated by the medicines segment due to the rising prevalence of different across animal population.

Region:

On the basis of region, market is analyzed across North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

• North America: Rigid regulatory frameworks, advanced infrastructure, and established players make this region lead in the Veterinary CRO and CDMO market. The United States is home to a highly developed pharmaceutical industry, and massive investment is being made in animal healthcare, further dominating the CRO and CDMO activities in North America. There are many large CRO and CDMOs in this region, which offer services from early drug discovery up to commercial manufacturing. Additionally, leading pharmaceutical companies and biotechnology firms in North America create robust demand for services in CRO and CDMO.

Asia Pacific: The region is growing fast in terms of pet adoption, disposable income, and investments in the animal healthcare sector. Countries, such as China, India, and Japan will be high-growth markets for the veterinary industry, thus paving the way for the CRO and CDMO industries. High population counts and increasing pet penetrations characterize this region, with growing demand for veterinary products and services. In addition, the growing concern about animal welfare and food safety is offering a favorable environment for the CRO and CDMO market.

Veterinary CRO & CDMO Market Report Scope:

Segmentation:

By Animal Type:

• Companion Animals
• Livestock Animals

By Service:

• Discovery
• Development
• Manufacturing
• Packaging and Labeling
• Market Approval and Post-Marketing

By Application:

• Medicines
• Medical Devices

By Region:

North America

• U.S.
• Canada

Europe

• Germany
• U.K.
• France
• Russia
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• Israel
• South Africa
• Rest of Middle East & Africa

The major players competing the veterinary CRO & CDMO market are Labcorp Drug Development, Oncovet Clinical Research (OCR), Charles River Laboratories, and others. These players are adopting strategic partnerships strategies to strengthen their position in the market.

List of Key Players in the Market:

• Labcorp Drug Development
• Charles River Laboratories
• Clinvet.
• Klifovet GmbH
• Oncovet Clinical Research (OCR)
• Knoell Triveritasm
• Vetspin
• Inotiv

                     To Access More Companies, Download Free Sample PDF

• In June 2023, Transpharmation Canada Ltd., the largest niche neuroscience-specialized small and large animal contract research organization (CRO), and a leading neurocognitive focused biotechnology company, and Veterinary Health Research Centers LLC (VHRC), a niche CRO specializing in providing disease-relevant canines and felines with spontaneous naturally occurring conditions for researchers, have announced their strategic marketing partnership at the Animal Health, Nutrition & Technology Innovation USA Conference. Designed to accelerate drug discovery programs by providing high-quality, translational drug discovery services, this collaboration will enable a seamless transition of preclinical work conducted by Transpharmation into Proof of Concept or pre-IND/INAD clinical trials using animals with real-world conditions traditionally unavailable in research colonies.
• In May 2023, Argenta, the only combined global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) dedicated to animal health and nutrition, tannounced that it has agreed to acquire the CRO services of Midwest Veterinary Services, Inc., a pioneer in the veterinary clinical space.

More Related Reports

Farm Animal Healthcare Market
Animal Parasiticides Market
Drug Discovery Services Market
Drug Discovery Informatics Market
Animal Health Market